Oncocdxsp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2020-11-02
Share capital
5 000,00 PLN
Activity description

Oncocdx is a non-profit research organization founded by researchers from leading institutes and universities. It provides comprehensive genomic profiling and raw-data analysis to support personalized diagnostics and companion diagnostics, including complex projects.

Registered address
ul. Księcia Witolda 1, 10-067 Olsztyn, Poland
Website
oncocdx.orgWebsite active
Social media
Electronic delivery address
AE:PL-56211-22349-JUUCJ-28

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 58.82kMedianUSD 72.17kAverageUSD 3.24m
Net profit
This companyUSD 7.26kMedianUSD 120.67AverageUSD 92.92k
Operating costs
This companyUSD 51.56kMedianUSD 75.89kAverageUSD 3.04m
Assets
This companyUSD 143.33kMedianUSD 121.07kAverageUSD 3.90m

Bank accounts

Registered as a VAT taxpayer on 2020-11-07. Active

  • mBank
    61 1140 2004 0000 3902 8062 5838

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

PurposeGross amount
Aid for SME access to finance — aid for start-ups
$171.1K
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$306
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$22,090

European Funds

ProjectEU co-financing
OncoCDx – diagnostyka towarzysząca w immunoterapii nowotworów
$175.7K

Tenders

No recorded participation in tenders.

Authorized Representatives

Rafał Damian Urniaż – President of the Management Board
Przemysław Maciej Pasieczny – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Przemysław Maciej Pasieczny (40)
10$135.0610%
Rafał Damian Urniaż (40)
90$1,215.5690%

Beneficial owners

Person
Rafał Damian Urniaż (40)

Competitors

Name
Gcp-Service International Ltd. & Co. KgBranch (foreign co.)
IntelliseqS.A.
AI Corelabsp. z o.o.
Xenstatssp. z o.o.
Digital Pathology Teamsp. z o.o.
Biostat Research and Developmentsp. z o.o.
Zawamedsp. z o.o.
Orphinic ScientificS.A.
CannamedaiS.A.
Medaisp. z o.o.

Change history

DateEvent
2024-07-24Business resumed
2024-01-31Business suspended
2022-07-14Address change
2021-04-07Address change
2020-11-02Entered in the register

FAQ

Last updated: 2026-04-22